Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction.
Vaupel, A., Bold, G., De Pover, A., Stachyra-Valat, T., Hergovich-Lisztwan, J., Kallen, J., Masuya, K., Furet, P.(2014) Bioorg Med Chem Lett 24: 2110-2114
- PubMed: 24704029 
- DOI: 10.1016/j.bmcl.2014.03.039
- Primary Citation of Related Structures:  
4OQ3 - PubMed Abstract: 
Capitalizing on crystal structure information obtained from a previous effort in the search for non peptide inhibitors of the p53-MDM2 interaction, we have discovered another new class of compounds able to disrupt this protein-protein interaction, an important target in oncology drug research ...